Where the Promise of NAMs Meets Practice
New Approach Methodologies (NAMs) have demonstrated significant potential to improve how safety and risk are evaluated in preclinical research and toxicology. NAMs have momentum, but adoption still lags. Learn what’s holding them back and what it will take to move forward.

NAMs have momentum, but adoption still lags. Learn what’s holding them back and what it will take to move forward.
Source: FierceBiotech